US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Valneva SE

6.38

+0.09001.43%

Volume:1.84K

Turnover:11.67K

Market Cap:533.20M

PE:-36.66

High:6.38

Open:6.27

Low:6.27

Close:6.29

Loading ...

Overview Company News Filings

Valneva price target lowered to $17 from $18 at H.C. Wainwright

Valneva Expects Further Sales Growth

Valneva 2025 Financial Outlook: Sales Revenue Projected At €170M-€180M, Total Revenue To Reach €180M-€190M; R&D Investments Of €90M-€100M

Valneva Preliminary 2024 Revenue €169.6M (+10% YoY), Product Sales Hit €163.3M (+13% YoY); Cash And Cash equivalents €168.3M

Press Release: Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook

Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook

Shareholding declaration Valneva SE - January 2025

Valneva jumps 19% after chikungunya vaccine wins UK approval

MHRA grants Valneva marketing authorization for chikungunya vaccine

Valneva Price Target Maintained With a $18.00/Share by HC Wainwright & Co.

Valneva Gets Marketing Authorization in UK for Chikungunya Vaccine; Shares Rise

MT Newswires Live

Sector Update: Health Care Stocks Gain Thursday

MT Newswires Live

Valneva Signs $33 Million Ixiaro Vaccine Supply Contract With US Defense Department; Shares Climb

MT Newswires Live

Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million

Valneva Is Maintained at Buy by HC Wainwright & Co.

Valneva reports Phase 2 results in children for its chikungunya vaccine

Favorable VLA1553-321 Phase 3 Study Results Boost VALN Stock

Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine

Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference

VALNEVA Declaration of shares and voting rights: December 31, 2024

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/VALN/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VALN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VALN\",,,,,undefined,":{"symbol":"VALN","market":"US","secType":"STK","nameCN":"Valneva SE","latestPrice":6.38,"timestamp":1746127002818,"preClose":6.29,"halted":0,"volume":1837,"delay":0,"floatShares":60632689,"shares":83573601,"eps":-0.174039,"marketStatus":"Trading","change":0.09,"latestTime":"05-01 15:18:11 EDT","open":6.27,"high":6.3802,"low":6.27,"amount":11672.951972,"amplitude":0.01752,"askPrice":6.49,"askSize":200,"bidPrice":6.4,"bidSize":18,"shortable":3,"etf":0,"ttmEps":-0.174039,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1746129600000},"marketStatusCode":2,"adr":0,"adrRate":2,"listingDate":1620273600000,"exchange":"NASDAQ","adjPreClose":6.29,"preHourTrading":{"tag":"盘前","latestPrice":6.02,"preClose":6.29,"latestTime":"09:20 EDT","volume":10,"amount":60.199999999999996,"timestamp":1746105641987},"postHourTrading":{"tag":"盘后","latestPrice":6.345,"preClose":6.345,"latestTime":"16:00 EDT","volume":13,"amount":81.77,"timestamp":1746043206443},"volumeRatio":0.120067},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VALN\",,,,,undefined,":{"symbol":"VALN","floatShares":60632689,"roa":"-10.03%","roe":"-7.91%","lyrEps":-0.174039,"volumeRatio":0.120067,"shares":83573601,"dividePrice":0,"high":6.3802,"amplitude":0.01752,"preClose":6.29,"low":6.27,"week52Low":3.62,"pbRate":"2.61","psRate":"2.79","week52High":9.5,"institutionHeld":0,"latestPrice":6.38,"committee":-0.834862,"eps":-0.174039,"divideRate":0,"volume":1837,"delay":0,"ttmEps":-0.174039,"open":6.27,"prevYearClose":4.372,"prevWeekClose":7.03,"prevMonthClose":6.345,"prevQuarterClose":6.71,"fiveDayClose":6.99,"twentyDayClose":6.9196,"sixtyDayClose":5.61,"earningDate":1746547200000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VALN\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512108371","title":"Valneva price target lowered to $17 from $18 at H.C. Wainwright","url":"https://stock-news.laohu8.com/highlight/detail?id=2512108371","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512108371?lang=en_us&edition=fundamental","pubTime":"2025-02-19 19:16","pubTimestamp":1739963782,"startTime":"0","endTime":"0","summary":"H.C. Wainwright lowered the firm’s price target on Valneva (VALN) to $17 from $18 and keeps a Buy rating on the shares following the Q4 report. The...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valneva-price-target-lowered-to-17-from-18-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valneva-price-target-lowered-to-17-from-18-at-h-c-wainwright?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","VALN","BK4139"],"gpt_icon":0},{"id":"2512358521","title":"Valneva Expects Further Sales Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2512358521","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512358521?lang=en_us&edition=fundamental","pubTime":"2025-02-18 16:13","pubTimestamp":1739866380,"startTime":"0","endTime":"0","summary":"Valneva expects further sales growth this year after it posted higher revenue in 2024.The French vaccine company said Tuesday that it expects total revenue in 2025 to grow to between 180 million euros and 190 million euros  with a positive cashflow. It expects to reach R&D investments of between 90 million and 100 million euros for this year.Its full-year revenue rose 10% to 169.6 million euros despite lower-than anticipated sales of its attenuated chikungunya vaccine in the U.S.Its cash and cash equivalents stood at 168.3 million euros as of Dec. 31.The company will publish its audited full-year results on Mar. 20.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VALN"],"gpt_icon":0},{"id":"2512184078","title":"Valneva 2025 Financial Outlook: Sales Revenue Projected At €170M-€180M, Total Revenue To Reach €180M-€190M; R&D Investments Of €90M-€100M","url":"https://stock-news.laohu8.com/highlight/detail?id=2512184078","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512184078?lang=en_us&edition=fundamental","pubTime":"2025-02-18 14:47","pubTimestamp":1739861239,"startTime":"0","endTime":"0","summary":"2025 Financial OutlookSales revenues expected to grow to €170-180 million, driving positive cash-flows for the overall commercial businessTotal revenues expected to reach €180-190 millionTotal R&amp;D investments","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43773009/valneva-2025-financial-outlook-sales-revenue-projected-at-170m-180m-total-revenue-to-reach-180m-190","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSS","VALN"],"gpt_icon":0},{"id":"2512840731","title":"Valneva Preliminary 2024 Revenue €169.6M (+10% YoY), Product Sales Hit €163.3M (+13% YoY); Cash And Cash equivalents €168.3M","url":"https://stock-news.laohu8.com/highlight/detail?id=2512840731","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512840731?lang=en_us&edition=fundamental","pubTime":"2025-02-18 14:45","pubTimestamp":1739861112,"startTime":"0","endTime":"0","summary":"Met 2024 growth targets for sales revenue (+13% vs 2023) and total revenues (+10% vs 2023)Strong year-end cash position of €168.3 millionSubstantial clinical and regulatory progress in 2024, leading to multiple","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/02/43773005/valneva-preliminary-2024-revenue-169-6m-10-yoy-product-sales-hit-163-3m-13-yoy-cash-and-cash-equiva","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Valneva Preliminary 2024 Revenue €169.6M (+10% YoY), Product Sales Hit €163.3M (+13% YoY); Cash And Cash equivalents €168.3M","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VALN"],"gpt_icon":0},{"id":"2512897841","title":"Press Release: Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2512897841","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512897841?lang=en_us&edition=fundamental","pubTime":"2025-02-18 14:00","pubTimestamp":1739858400,"startTime":"0","endTime":"0","summary":"-- Met 2024 growth targets for sales revenue  and total. -- Strong year-end cash position of EUR168.3 million. -- Substantial clinical and regulatory progress in 2024, leading to multiple. anticipated data readouts, product approvals and label extensions in 2025. Saint-Herblain , February 18, 2025 -- Valneva SE  a specialty vaccine company, today reported its preliminary unaudited full-year 2024 revenue and cash results and provided a 2025 outlook. The Company will publish its 2024 audited consolidated financial statements and host an analyst call on March 20, 2025.Peter Bühler, Valneva's Chief Financial Officer, commented, \"Once again, we successfully delivered double digit sales growth, despite lower than anticipated launch-year IXCHIQ sales in the U.S. We made significant clinical and regulatory progress last year, setting the stage for several important catalysts to drive value in 2025, most notably with the first Phase 3 study results for our lead Lyme disease vaccine candidate, V","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VALN"],"gpt_icon":0},{"id":"2512189659","title":"Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2512189659","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512189659?lang=en_us&edition=fundamental","pubTime":"2025-02-18 14:00","pubTimestamp":1739858400,"startTime":"0","endTime":"0","summary":"Met 2024 growth targets for sales revenue  and total revenues . Substantial clinical and regulatory progress in 2024, leading to multiple anticipated data readouts, product approvals and label extensions in 2025. 2025 outlook reflects solid revenue growth and positive commercial cash flows to support strategic R&D investments with lower operating cash burn. Saint-Herblain , February 18, 2025 – Valneva SE  a specialty vaccine company, today reported its preliminary unaudited full-year 2024 revenue and cash results1 and provided a 2025 outlook. The Company will publish its 2024 audited consolidated financial statements and host an analyst call on March 20, 2025.Total revenues were 169.6 million for the year ended December 31, 2024 compared to 153.7 million in the year ended December 31, 2023, an increase of 10%. Product sales revenue reached 163.3 million for the year ended December 31, 2024 compared to 144.6 million in the same period of 2023, an increase of 13%. Secured three additiona","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-reports-preliminary-unaudited-2024-060000747.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Valneva Reports Preliminary Unaudited 2024 Revenue and Cash and Provides 2025 Outlook","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VALN","INRLF"],"gpt_icon":0},{"id":"2509209231","title":"Shareholding declaration Valneva SE - January 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2509209231","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509209231?lang=en_us&edition=fundamental","pubTime":"2025-02-07 01:00","pubTimestamp":1738861200,"startTime":"0","endTime":"0","summary":"Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain Regulated market of Euronext Paris - Compartment B. Number of shares composing the share capital of Valneva. Total number of voting rights including suspended voting rights*. Total number of voting rights excluding suspended voting rights**. 162,521,524  ordinary shares with a par value of 0.15 each. Double voting rights granted on 2282 ordinary shares. * Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.** Net  voting rights.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/shareholding-declaration-valneva-se-january-170000380.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["VALN","INRLF","BK4139"],"gpt_icon":0},{"id":"2509152263","title":"Valneva jumps 19% after chikungunya vaccine wins UK approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2509152263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509152263?lang=en_us&edition=fundamental","pubTime":"2025-02-06 07:10","pubTimestamp":1738797009,"startTime":"0","endTime":"0","summary":"Shares of Valneva (VALN), a specialty vaccine company closed up over $1.00 per share or almost 19% to close the regular session at $6.67 per share ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valneva-jumps-19-after-chikungunya-vaccine-wins-uk-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valneva-jumps-19-after-chikungunya-vaccine-wins-uk-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4539","VALN"],"gpt_icon":0},{"id":"2509149268","title":"MHRA grants Valneva marketing authorization for chikungunya vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2509149268","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509149268?lang=en_us&edition=fundamental","pubTime":"2025-02-06 07:05","pubTimestamp":1738796734,"startTime":"0","endTime":"0","summary":"Valneva (VALN) announced that the Medicines and Healthcare products Regulatory Agency or MHRA has granted marketing authorization in the United Kin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mhra-grants-valneva-marketing-authorization-for-chikungunya-vaccine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mhra-grants-valneva-marketing-authorization-for-chikungunya-vaccine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","VALN"],"gpt_icon":0},{"id":"2509235190","title":"Valneva Price Target Maintained With a $18.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2509235190","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509235190?lang=en_us&edition=fundamental","pubTime":"2025-02-06 00:03","pubTimestamp":1738771380,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VALN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 05, 2025 11:03 ET (16:03 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VALN"],"gpt_icon":0},{"id":"2509623323","title":"Valneva Gets Marketing Authorization in UK for Chikungunya Vaccine; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2509623323","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509623323?lang=en_us&edition=fundamental","pubTime":"2025-02-05 23:52","pubTimestamp":1738770757,"startTime":"0","endTime":"0","summary":"Valneva  secured marketing authorization in the UK for its Ixchiq vaccine for chikungunya, a mosquito-borne viral disease.The vaccine, manufactured at the company's leading production site in Livingston, Scotland, got the approval from the Medicines and Healthcare products Regulatory Agency,The single-dose vaccine is for active immunization for the prevention of disease caused by the chikungunya virus in people 18 years of age and older, Valneva said Wednesday in a statement.The vaccine is approved in the US, Europe and Canada in adults, and Valneva expects to get marketing approval in Brazil in Q1.Valneva submitted label extension applications in the US, Europe and Canada to possibly extend the use of Ixchiq to adolescents aged 12 to 17 years and plans to submit a label extension application in the UK.The company's shares rose 14% in recent Wednesday trading.Price: 6.43, Change: +0.82, Percent Change: +14.69","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4139","VALN"],"gpt_icon":0},{"id":"2507660841","title":"Sector Update: Health Care Stocks Gain Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=2507660841","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507660841?lang=en_us&edition=fundamental","pubTime":"2025-01-31 05:02","pubTimestamp":1738270955,"startTime":"0","endTime":"0","summary":"Health care stocks rose Thursday with the NYSE Health Care Index up 1% and the Health Care Select Sector SPDR Fund  adding 1.2%.The iShares Biotechnology ETF  advanced 1%.In corporate news, Kazia Therapeutics'  shares jumped 38% after the company announced the regulatory approval and launch of a trial evaluating the combination of its investigational drug paxalisib and immunotherapy in people with advanced breast cancer.Valneva  shares rose 3.6% after the company won a $32.8 million contract from the US Department of Defense for the supply of Ixiaro, a Japanese encephalitis vaccine.Ironwood Pharmaceuticals  shares slumped 38%, a day after the company announced a 50% cut in its workforce due to \"ongoing pricing pressures.\"Cargo Therapeutics  shares tumbled 74%, a day after the company announced plans to discontinue a phase 2 trial of firicabtagene autoleucel for people with large B-cell lymphoma and reduce its workforce by 50%.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","XLV","BK4588","CRGX","BK4581","BK4539","VALN","IBB","BK4585","IRWD","KZIA"],"gpt_icon":0},{"id":"2507667598","title":"Valneva Signs $33 Million Ixiaro Vaccine Supply Contract With US Defense Department; Shares Climb","url":"https://stock-news.laohu8.com/highlight/detail?id=2507667598","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507667598?lang=en_us&edition=fundamental","pubTime":"2025-01-31 01:07","pubTimestamp":1738256871,"startTime":"0","endTime":"0","summary":"Valneva  said Thursday it has been awarded a $32.8 million contract by the US Department of Defense for the supply of Ixiaro, a Japanese encephalitis vaccine.The one-year contract takes effect immediately, the company said.Shares of Valneva were up more than 4% in recent trading.Price: 5.29, Change: +0.22, Percent Change: +4.26","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4539","BK4139","VALN"],"gpt_icon":0},{"id":"2507675398","title":"Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2507675398","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507675398?lang=en_us&edition=fundamental","pubTime":"2025-01-31 00:45","pubTimestamp":1738255500,"startTime":"0","endTime":"0","summary":"Saint Herblain , January 30, 2025 – Valneva SE , a specialty vaccine company, today announced the signing of a new $32.8 million contract with the United States  Department of Defense  for the supply of its Japanese encephalitis  vaccine, IXIARO.Under this new one-year contract, the DoD will buy a minimum of $32.8 million worth of IXIARO vaccines and has the possibility to purchase additional doses during the coming twelve months.Deliveries of IXIARO doses have continued in 2024 under the supply contract signed in September 20231. The new contract will commence immediately.Dipal Patel, Chief Commercial Officer of Valneva commented, “We are honored to continue our long-term relationship with the DoD. The U.S. military has trusted IXIARO for over ten years to help protect military personnel, their families, civilian government service personnel, and government contractors from this potentially deadly disease.”IXIARO is the only JE vaccine approved by the U.S. Food and Drug Administration","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-announces-ixiaro-supply-contract-164500837.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Valneva Announces New IXIARO® Supply Contract with the U.S. Government Worth a Minimum of $32.8 Million","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","VALN","INRLF"],"gpt_icon":0},{"id":"2505928370","title":"Valneva Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2505928370","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505928370?lang=en_us&edition=fundamental","pubTime":"2025-01-23 20:03","pubTimestamp":1737633780,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/VALN/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 23, 2025 07:03 ET (12:03 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VALN"],"gpt_icon":0},{"id":"2505360775","title":"Valneva reports Phase 2 results in children for its chikungunya vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2505360775","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505360775?lang=en_us&edition=fundamental","pubTime":"2025-01-23 00:55","pubTimestamp":1737564936,"startTime":"0","endTime":"0","summary":"Valneva (VALN) announced results for its Phase 2 clinical trial evaluating the safety and immunogenicity of two different dose levels of its single...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/valneva-reports-phase-2-results-in-children-for-its-chikungunya-vaccine?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/valneva-reports-phase-2-results-in-children-for-its-chikungunya-vaccine?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","VALN"],"gpt_icon":0},{"id":"2505278755","title":"Favorable VLA1553-321 Phase 3 Study Results Boost VALN Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2505278755","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505278755?lang=en_us&edition=fundamental","pubTime":"2025-01-21 20:05","pubTimestamp":1737461100,"startTime":"0","endTime":"0","summary":"Valneva SE VALN, a specialty vaccine company, recently reported positive Phase 3 - VLA1553-321 data in adolescents  for its single-shot chikungunya virus  vaccine, IXCHIQ. For investors’ note, IXCHIQ is the world’s first and only licensed chikungunya vaccine available to address this significant unmet medical need.The trial data supports and strengthens the pivotal data previously reported for adolescents in the United States, Europe and Canada. Data from this trial are also expected to support the licensure of IXCHIQ in Brazil.The new favorable data from the Phase 3 trial helped Valneva advance the furthest along the clinical development timeline.Subsequent to the news, the share price of VALN jumped 1.4% to $4.37 yesterday.The latest development is capable of generating positive market sentiment, considering the rising number of chikungunya cases in select geographies. We therefore expect market sentiment toward VALN stock to be positive surrounding this news.Additionally, the compan","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/favorable-vla1553-321-phase-3-120500966.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance_au","symbols":["BK4567","CEPI","OMCL","BK4139","BK4504","INRLF","BK4548","BK7007","RMD.AU","BK4156","LU2008162690.USD","BK4588","BK4082","BK4539","BK4585","LU2177674079.SGD","VCYT","RMD","BK7501","VALN","BK4167"],"gpt_icon":0},{"id":"2505238242","title":"Valneva Reports High Sustained Immune Response in Adolescents One Year After Single Vaccination with its Chikungunya Vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2505238242","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505238242?lang=en_us&edition=fundamental","pubTime":"2025-01-21 00:45","pubTimestamp":1737391500,"startTime":"0","endTime":"0","summary":"Geometric mean antibody titers  consistently surpassed the seroresponse threshold defined with the U.S. Food and Drug Administration 7 as the surrogate of protection in baseline seronegative participants who received a single dose of the vaccine.Conducted in collaboration with Instituto Butantan in Brazil and funded by the Coalition for Epidemic Preparedness Innovations  with support from the European Union ’s Horizon 2020 program, the VLA1553-321 trial represents the first clinical trial conducted in an endemic area and with individuals previously infected with CHIKV. This trial supported the submission of label extension applications to the U.S. Food and Drug Administration 8, the European Medicines Agency  and Health Canada9 to po","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-reports-high-sustained-immune-164500324.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INRLF","CEPI","VALN","SII","BK4156","BK4139","BK4135"],"gpt_icon":0},{"id":"2501252128","title":"Valneva to Meet with Investors during the J.P. Morgan Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2501252128","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2501252128?lang=en_us&edition=fundamental","pubTime":"2025-01-07 00:45","pubTimestamp":1736181900,"startTime":"0","endTime":"0","summary":"Saint Herblain , January 6, 2025 – Valneva SE , a specialty vaccine company, today announces that members of its management team will meet one-on-one with existing shareholders and hold meetings with other institutional specialist investors during the 43nd Annual J.P. Morgan Healthcare Conference, January 13-15, 2025 in San Francisco.Valneva’s CEO Thomas Lingelbach and CFO Peter Bühler will discuss the Company’s commercial portfolio of vaccines, which is expected to generate 160 - 170 million in revenues in 2024, and highlight upcoming catalysts from its clinical development pipeline, including the pivotal data readout for its Lyme disease vaccine later this year.To schedule a 1on1 investor meeting with Valneva, institutional investors and analysts can contact Valneva’s investor relations department at investors@valneva.com.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-meet-investors-during-j-164500780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2271345857.HKD","BK4137","LU0912757837.SGD","LU0158827948.USD","VALN","BK4127","BK4585","LU1363072403.SGD","LU2357305700.SGD","LU1732800096.USD","LU0971096721.USD","LU2089283258.USD","LU0006306889.USD","BK4516","INRLF","LU0267386448.USD","LU1720051108.HKD","BK4504","LU0314104364.USD","LU2023251221.USD","LU2089284900.SGD","LU0106261372.USD","HCSG","IE00BKVL7J92.USD","LU0795875086.SGD","LU1162221912.USD","LU1732799900.SGD","IE00BZ1G4Q59.USD","LU1720051017.SGD","LU1548497426.USD","LU0158827781.USD","LU2347655156.SGD","LU0106831901.USD","BK4588","LU1074936037.SGD","BK4581","LU0320765646.SGD","LU1989772840.SGD","BK4139","LU1989772923.USD","ISBC","BK4534","LU0225283273.USD","LU2028103732.USD","BK4211","LU1668664300.SGD","LU0098860793.USD","LU2111349929.HKD","BK4539","LU0795875169.SGD"],"gpt_icon":0},{"id":"2500149174","title":"VALNEVA  Declaration of shares and voting rights: December 31, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2500149174","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500149174?lang=en_us&edition=fundamental","pubTime":"2025-01-04 01:00","pubTimestamp":1735923600,"startTime":"0","endTime":"0","summary":"Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain Regulated market of Euronext Paris - Compartment B. Number of shares composing the share capital of Valneva. Total number of voting rights including suspended voting rights*. Total number of voting rights excluding suspended voting rights**. 162,521,524 ordinary shares with a par value of 0.15 each. Transfer into bearer form of 300 shares with double voting rightsSale of 150 shares with double voting rightsDefinitive attribution of 27,521 free ordinary shares Double voting rights granted on 6,177 ordinary shares. December 2, 2024December 5, 2024December 6, 2024Between December 1& 28, 2024. * Theoretical voting rights. This number is used as the basis for calculating threshold crossings. In accordance with Article 223-11 of the AMF General Regulations, this number is calculated on the basis of all shares to which voting rights are attached, including those for which voting rights have been suspended.** Net","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/valneva-declaration-shares-voting-rights-170000544.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","INRLF","VALN"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":3,"totalSize":83,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VALN\",params:#limit:5,,,undefined,":[{"date":"2025-05-07","symbol":"VALN","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.31,"defaultRemindTime":1746604800000,"name":null,"time":"Pre-Market","dateTimestamp":1746590400000,"actualEps":null},{"market":"US","date":"2025-03-20","symbol":"VALN","fiscalQuarterEnding":"2024/12","expectedEps":-0.22,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742443200000,"reportTimeType":"pre","actualEps":-0.54},{"market":"US","date":"2024-11-07","symbol":"VALN","fiscalQuarterEnding":"2024/09","expectedEps":-0.3,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"pre","actualEps":-0.15},{"market":"US","date":"2024-08-13","symbol":"VALN","fiscalQuarterEnding":"2024/06","expectedEps":-0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2024-05-07","symbol":"VALN","fiscalQuarterEnding":"2024/03","expectedEps":0.77,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715054400000,"reportTimeType":"pre","actualEps":0.89}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VALN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VALN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.25,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1668225600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VALN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VALN","date":"2025-04-30","current":-39.442754,"percent":0.167208,"low":-218.184634,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"high":13.644639,"avg":-19.781018,"sd":26.023364,"marketCap":548054700.48},"quantilePoints":[{"date":"2020-05-01","current":-218.184634,"twenty":-43.597526,"median":-25.367192,"eighty":-4.691885,"marketCap":418607262.93},{"date":"2020-05-08","current":-45.383648,"twenty":-43.681489,"median":-25.42373,"eighty":-4.691885,"marketCap":385512246.83},{"date":"2020-05-15","current":-44.324108,"twenty":-43.812284,"median":-25.440934,"eighty":-4.691885,"marketCap":375411764.07},{"date":"2020-05-22","current":-44.618425,"twenty":-43.817691,"median":-25.546607,"eighty":-4.708823,"marketCap":380374502.18},{"date":"2020-05-29","current":-44.265245,"twenty":-43.878266,"median":-25.588418,"eighty":-4.708823,"marketCap":385124852.7},{"date":"2020-06-05","current":-44.561073,"twenty":-43.948952,"median":-25.609238,"eighty":-4.708823,"marketCap":394675142.6},{"date":"2020-06-12","current":-45.620649,"twenty":-44.085703,"median":-25.643724,"eighty":-4.708823,"marketCap":401199236.99},{"date":"2020-06-19","current":-53.508607,"twenty":-44.205807,"median":-25.710593,"eighty":-4.722373,"marketCap":468776845.4},{"date":"2020-06-26","current":-51.56605,"twenty":-44.265245,"median":-25.791207,"eighty":-4.725761,"marketCap":452366222.4},{"date":"2020-07-02","current":-55.74549,"twenty":-44.292711,"median":-25.845734,"eighty":-4.725761,"marketCap":490460040.47},{"date":"2020-07-10","current":-49.741224,"twenty":-44.402723,"median":-25.957127,"eighty":-4.735924,"marketCap":440405949.77},{"date":"2020-07-17","current":-52.095838,"twenty":-44.500967,"median":-26.178353,"eighty":-4.742699,"marketCap":465945177.14},{"date":"2020-07-24","current":-57.158259,"twenty":-44.576376,"median":-26.252094,"eighty":-4.742699,"marketCap":520261144.45},{"date":"2020-07-31","current":-55.510029,"twenty":-44.599331,"median":-26.325836,"eighty":-4.752862,"marketCap":513925807.41},{"date":"2020-08-07","current":-20.100131,"twenty":-44.599331,"median":-26.252094,"eighty":-4.759638,"marketCap":591868791.84},{"date":"2020-08-14","current":-19.583798,"twenty":-44.599331,"median":-26.18097,"eighty":-4.769801,"marketCap":578848125.89},{"date":"2020-08-21","current":-20.579584,"twenty":-44.599331,"median":-26.149802,"eighty":-4.776576,"marketCap":605629838.61},{"date":"2020-08-28","current":-19.436274,"twenty":-44.599331,"median":-25.899888,"eighty":-4.776576,"marketCap":577562738.19},{"date":"2020-09-04","current":-17.38938,"twenty":-44.576376,"median":-25.809643,"eighty":-4.776576,"marketCap":512410338.52},{"date":"2020-09-11","current":-18.809297,"twenty":-44.560468,"median":-25.735902,"eighty":-4.783351,"marketCap":556219063.68},{"date":"2020-09-18","current":-24.267682,"twenty":-44.549389,"median":-25.669484,"eighty":-4.793514,"marketCap":719249284.61},{"date":"2020-09-25","current":-25.484754,"twenty":-44.521026,"median":-25.609238,"eighty":-4.793514,"marketCap":739700382.25},{"date":"2020-10-02","current":-25.263468,"twenty":-44.501102,"median":-25.617263,"eighty":-4.800289,"marketCap":739290097.22},{"date":"2020-10-09","current":-24.710253,"twenty":-44.487836,"median":-25.588418,"eighty":-4.810452,"marketCap":729424019.85},{"date":"2020-10-16","current":-25.152825,"twenty":-44.468388,"median":-25.573467,"eighty":-4.810452,"marketCap":736138559.04},{"date":"2020-10-23","current":-23.161252,"twenty":-44.442076,"median":-25.541667,"eighty":-4.817228,"marketCap":684912885.89},{"date":"2020-10-30","current":-22.460514,"twenty":-44.402801,"median":-25.444403,"eighty":-4.827391,"marketCap":653896464.28},{"date":"2020-11-06","current":-8.555896,"twenty":-44.376488,"median":-25.440934,"eighty":-4.827391,"marketCap":626984846.65},{"date":"2020-11-13","current":-8.201859,"twenty":-44.337213,"median":-25.405295,"eighty":-4.827391,"marketCap":597913187.09},{"date":"2020-11-20","current":-8.260865,"twenty":-44.331832,"median":-25.30517,"eighty":-4.827391,"marketCap":603928804.55},{"date":"2020-11-27","current":-9.160709,"twenty":-44.313642,"median":-25.263468,"eighty":-4.827391,"marketCap":675158735.05},{"date":"2020-12-04","current":-9.384421,"twenty":-44.271779,"median":-25.238145,"eighty":-4.830779,"marketCap":702054944.17},{"date":"2020-12-11","current":-10.166457,"twenty":-44.270472,"median":-25.145967,"eighty":-4.844329,"marketCap":759085570.49},{"date":"2020-12-18","current":-12.394519,"twenty":-44.265245,"median":-24.864965,"eighty":-4.844329,"marketCap":934386351.96},{"date":"2020-12-24","current":-11.302621,"twenty":-44.265245,"median":-24.780636,"eighty":-4.844329,"marketCap":849060143.8},{"date":"2020-12-31","current":-11.435419,"twenty":-44.218002,"median":-24.720537,"eighty":-4.844329,"marketCap":862293553.52},{"date":"2021-01-08","current":-11.082813,"twenty":-44.206191,"median":-24.528109,"eighty":-4.844329,"marketCap":836626157.24},{"date":"2021-01-15","current":-14.609833,"twenty":-44.205884,"median":-24.488967,"eighty":-4.857879,"marketCap":1088875061.06},{"date":"2021-01-22","current":-13.399726,"twenty":-44.205807,"median":-24.419432,"eighty":-4.861267,"marketCap":1005493246.5},{"date":"2021-01-29","current":-13.990022,"twenty":-44.205807,"median":-24.291612,"eighty":-4.861267,"marketCap":1046857158.29},{"date":"2021-02-05","current":-21.168008,"twenty":-44.166685,"median":-24.188992,"eighty":-4.861267,"marketCap":1569686869.96},{"date":"2021-02-12","current":-19.590083,"twenty":-44.133314,"median":-24.083277,"eighty":-4.861267,"marketCap":1463593633.5},{"date":"2021-02-19","current":-18.280108,"twenty":-44.107079,"median":-24.055115,"eighty":-4.868042,"marketCap":1367215478.04},{"date":"2021-02-26","current":-15.789643,"twenty":-44.075015,"median":-23.953759,"eighty":-4.878205,"marketCap":1230178441.62},{"date":"2021-03-05","current":-14.535592,"twenty":-44.046669,"median":-23.861991,"eighty":-4.878205,"marketCap":1115070731.47},{"date":"2021-03-12","current":-14.450088,"twenty":-43.990861,"median":-23.852403,"eighty":-4.878205,"marketCap":1111291706.68},{"date":"2021-03-19","current":-14.421587,"twenty":-43.95994,"median":-23.67113,"eighty":-4.878205,"marketCap":1105271686.5},{"date":"2021-03-26","current":-14.649597,"twenty":-43.943458,"median":-23.55764,"eighty":-4.878205,"marketCap":1112550386.84},{"date":"2021-04-01","current":-15.248121,"twenty":-43.930735,"median":-23.416221,"eighty":-4.878205,"marketCap":1155279742.32},{"date":"2021-04-09","current":-17.499713,"twenty":-43.879449,"median":-23.302421,"eighty":-4.878205,"marketCap":1339107542.48},{"date":"2021-04-16","current":-17.955731,"twenty":-43.877871,"median":-23.179693,"eighty":-4.878205,"marketCap":1385030427.65},{"date":"2021-04-23","current":-16.331165,"twenty":-43.865835,"median":-22.976847,"eighty":-4.881593,"marketCap":1268378617.78},{"date":"2021-04-30","current":-19.965063,"twenty":-43.816686,"median":-22.77089,"eighty":-4.895143,"marketCap":1546505840.25},{"date":"2021-05-07","current":-18.896475,"twenty":-43.812664,"median":-22.180262,"eighty":-4.895143,"marketCap":1478853561.01},{"date":"2021-05-14","current":-18.521699,"twenty":-43.812588,"median":-21.978065,"eighty":-4.895143,"marketCap":1447588034.96},{"date":"2021-05-21","current":-12.751807,"twenty":-43.812284,"median":-21.796656,"eighty":-4.895143,"marketCap":1412194659.35},{"date":"2021-05-28","current":-11.652514,"twenty":-43.812284,"median":-21.556929,"eighty":-4.895143,"marketCap":1290453740.4},{"date":"2021-06-04","current":-12.400033,"twenty":-43.812284,"median":-21.313441,"eighty":-4.895143,"marketCap":1370898432.9},{"date":"2021-06-11","current":-12.751807,"twenty":-43.755538,"median":-21.090166,"eighty":-4.895143,"marketCap":1401603626.47},{"date":"2021-06-18","current":-12.334076,"twenty":-43.746697,"median":-20.856192,"eighty":-4.912082,"marketCap":1328687749.85},{"date":"2021-06-25","current":-11.828401,"twenty":-43.736958,"median":-20.468941,"eighty":-4.912082,"marketCap":1283649160.4},{"date":"2021-07-02","current":-12.630885,"twenty":-43.681489,"median":-20.339858,"eighty":-4.912082,"marketCap":1359211263.62},{"date":"2021-07-09","current":-12.564927,"twenty":-43.629019,"median":-20.118572,"eighty":-4.912082,"marketCap":1354519736.62},{"date":"2021-07-16","current":-12.136203,"twenty":-43.615901,"median":-19.965063,"eighty":-4.912082,"marketCap":1302123273.11},{"date":"2021-07-23","current":-13.026631,"twenty":-43.615598,"median":-19.666514,"eighty":-4.912082,"marketCap":1392398334.31},{"date":"2021-07-30","current":-13.037624,"twenty":-43.601125,"median":-19.583798,"eighty":-4.912082,"marketCap":1405310448.4},{"date":"2021-08-06","current":-13.466348,"twenty":-43.574769,"median":-19.537399,"eighty":-4.912082,"marketCap":1439399122.46},{"date":"2021-08-13","current":-9.031199,"twenty":-43.554066,"median":-19.436274,"eighty":-4.912082,"marketCap":1333823072.93},{"date":"2021-08-20","current":-9.772507,"twenty":-43.550313,"median":-19.355826,"eighty":-4.912082,"marketCap":1428806710.28},{"date":"2021-08-27","current":-13.032666,"twenty":-43.545653,"median":-19.251869,"eighty":-4.912082,"marketCap":1923213368.71},{"date":"2021-09-03","current":-16.138703,"twenty":-43.496678,"median":-19.050185,"eighty":-4.912082,"marketCap":2400246131.91},{"date":"2021-09-10","current":-15.902522,"twenty":-43.460755,"median":-18.930671,"eighty":-4.912082,"marketCap":2354209006.39},{"date":"2021-09-17","current":-9.244538,"twenty":-43.429392,"median":-18.831946,"eighty":-4.912082,"marketCap":1358119132.53},{"date":"2021-09-24","current":-10.520018,"twenty":-43.418911,"median":-18.702304,"eighty":-4.912082,"marketCap":1541700003.51},{"date":"2021-10-01","current":-10.152855,"twenty":-43.398728,"median":-18.607602,"eighty":-4.912082,"marketCap":1473058489.45},{"date":"2021-10-08","current":-9.96089,"twenty":-43.383722,"median":-18.45965,"eighty":-4.912082,"marketCap":1442697950.47},{"date":"2021-10-15","current":-9.577779,"twenty":-43.325826,"median":-18.335552,"eighty":-4.922245,"marketCap":1390589081.21},{"date":"2021-10-22","current":-15.164817,"twenty":-43.287962,"median":-18.226492,"eighty":-4.92902,"marketCap":2207656544.14},{"date":"2021-10-29","current":-16.056507,"twenty":-43.25094,"median":-18.034797,"eighty":-4.92902,"marketCap":2323681768.04},{"date":"2021-11-05","current":-14.859108,"twenty":-43.184575,"median":-17.958959,"eighty":-4.92902,"marketCap":2148904537.79},{"date":"2021-11-12","current":-17.427971,"twenty":-43.156786,"median":-17.955731,"eighty":-4.92902,"marketCap":2497038206.07},{"date":"2021-11-19","current":-18.049199,"twenty":-43.150819,"median":-17.954173,"eighty":-4.92902,"marketCap":2557354752.63},{"date":"2021-11-26","current":-21.826939,"twenty":-43.141709,"median":-17.954173,"eighty":-4.92902,"marketCap":3091215201.99},{"date":"2021-12-03","current":-19.828934,"twenty":-43.128479,"median":-18.012734,"eighty":-4.92902,"marketCap":2801276249.01},{"date":"2021-12-10","current":-19.190916,"twenty":-43.082353,"median":-18.045217,"eighty":-4.92902,"marketCap":2717276542.6},{"date":"2021-12-17","current":-21.6952,"twenty":-43.02561,"median":-18.049199,"eighty":-4.92902,"marketCap":3061471834.48},{"date":"2021-12-23","current":-21.258609,"twenty":-43.012701,"median":-18.133149,"eighty":-4.92902,"marketCap":3010726187.62},{"date":"2021-12-31","current":-20.570139,"twenty":-42.961066,"median":-18.260425,"eighty":-4.92902,"marketCap":2927800125.1},{"date":"2022-01-07","current":-14.759057,"twenty":-42.960783,"median":-18.212242,"eighty":-4.932408,"marketCap":2094738393.06},{"date":"2022-01-14","current":-13.750466,"twenty":-42.95965,"median":-18.065989,"eighty":-4.945958,"marketCap":1965633407.2},{"date":"2022-01-21","current":-13.162121,"twenty":-42.95965,"median":-18.049199,"eighty":-4.945958,"marketCap":1868298618.58},{"date":"2022-01-28","current":-12.472916,"twenty":-42.947553,"median":-18.034797,"eighty":-4.945958,"marketCap":1742407533.21},{"date":"2022-02-04","current":-12.507426,"twenty":-42.854989,"median":-17.958959,"eighty":-4.945958,"marketCap":1791213902.05},{"date":"2022-02-11","current":-13.132369,"twenty":-42.833778,"median":-17.931531,"eighty":-4.945958,"marketCap":1874492871.81},{"date":"2022-02-18","current":-12.610156,"twenty":-42.833778,"median":-17.931531,"eighty":-4.945958,"marketCap":1788529970.53},{"date":"2022-02-25","current":-12.841299,"twenty":-42.833778,"median":-17.931531,"eighty":-4.945958,"marketCap":1810643459.89},{"date":"2022-03-04","current":-11.805779,"twenty":-42.833778,"median":-17.931531,"eighty":-4.945958,"marketCap":1612670420.21},{"date":"2022-03-11","current":-13.338219,"twenty":-42.833778,"median":-17.931531,"eighty":-4.945958,"marketCap":1827587115.17},{"date":"2022-03-18","current":-14.922025,"twenty":-42.833778,"median":-17.931531,"eighty":-4.945958,"marketCap":2065858627.21},{"date":"2022-03-25","current":-22.866341,"twenty":-42.833778,"median":-17.958959,"eighty":-4.945958,"marketCap":1844809487.97},{"date":"2022-04-01","current":-23.676221,"twenty":-42.833778,"median":-18.049199,"eighty":-4.945958,"marketCap":1918793105.96},{"date":"2022-04-08","current":-23.215059,"twenty":-42.833778,"median":-18.226492,"eighty":-4.945958,"marketCap":1853997954.1},{"date":"2022-04-14","current":-24.609577,"twenty":-42.833778,"median":-18.416116,"eighty":-4.945958,"marketCap":1952834996.22},{"date":"2022-04-22","current":-22.620554,"twenty":-42.833778,"median":-18.616247,"eighty":-4.945958,"marketCap":1790356988.25},{"date":"2022-04-29","current":-18.158096,"twenty":-42.833778,"median":-18.660826,"eighty":-4.945958,"marketCap":1405056559.17},{"date":"2022-05-06","current":-18.195389,"twenty":-42.833778,"median":-18.660826,"eighty":-4.945958,"marketCap":1383381571.14},{"date":"2022-05-13","current":-17.91003,"twenty":-42.833778,"median":-18.660826,"eighty":-4.945958,"marketCap":1337873805.56},{"date":"2022-05-20","current":-17.842445,"twenty":-42.833778,"median":-18.660826,"eighty":-4.945958,"marketCap":1350823076.27},{"date":"2022-05-27","current":-17.144066,"twenty":-42.833778,"median":-18.660826,"eighty":-4.959508,"marketCap":1318113089.78},{"date":"2022-06-03","current":-16.776103,"twenty":-42.833778,"median":-18.660826,"eighty":-4.959508,"marketCap":1290375423.37},{"date":"2022-06-10","current":-15.694743,"twenty":-42.833778,"median":-18.660826,"eighty":-4.959508,"marketCap":1185223120.07},{"date":"2022-06-17","current":-11.921997,"twenty":-42.833778,"median":-18.660826,"eighty":-4.959508,"marketCap":895228834.36},{"date":"2022-06-24","current":-18.998899,"twenty":-42.839081,"median":-18.754377,"eighty":-4.956121,"marketCap":1438224696.2},{"date":"2022-07-01","current":-15.041421,"twenty":-42.839081,"median":-18.773401,"eighty":-4.956121,"marketCap":1122771523.82},{"date":"2022-07-08","current":-15.627158,"twenty":-42.839081,"median":-18.773401,"eighty":-4.962896,"marketCap":1141442605.6},{"date":"2022-07-15","current":-15.199119,"twenty":-42.839081,"median":-18.773401,"eighty":-4.979834,"marketCap":1100655508.58},{"date":"2022-07-22","current":-14.742545,"twenty":-42.839081,"median":-18.773401,"eighty":-5.006936,"marketCap":1081562060.93},{"date":"2022-07-29","current":-14.493232,"twenty":-42.839081,"median":-18.773401,"eighty":-7.517387,"marketCap":1060885624.24},{"date":"2022-08-05","current":-14.616386,"twenty":-42.839081,"median":-18.773401,"eighty":-8.098598,"marketCap":1065336538.7},{"date":"2022-08-12","current":-7.475211,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":1214972810.42},{"date":"2022-08-19","current":-7.189807,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":1144298265.06},{"date":"2022-08-26","current":-6.840816,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":1083857429.29},{"date":"2022-09-02","current":-6.154664,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":978763284.51},{"date":"2022-09-09","current":-6.392747,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":1017441669.68},{"date":"2022-09-16","current":-5.999393,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":953114620.16},{"date":"2022-09-23","current":-4.198244,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":647060247.93},{"date":"2022-09-30","current":-4.55113,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":707433466.37},{"date":"2022-10-07","current":-5.236667,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":811527169.81},{"date":"2022-10-14","current":-5.484535,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":847288830.52},{"date":"2022-10-21","current":-5.56134,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":864631259.32},{"date":"2022-10-28","current":-5.847611,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":921703729.74},{"date":"2022-11-04","current":-5.856339,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":920242823.16},{"date":"2022-11-11","current":13.20723,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":1001700595.95},{"date":"2022-11-18","current":13.207528,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":1005044997.93},{"date":"2022-11-25","current":12.303161,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":939438527.61},{"date":"2022-12-02","current":12.706358,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":978364263.4},{"date":"2022-12-09","current":12.653603,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":979230750.34},{"date":"2022-12-16","current":11.918805,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":928039037.22},{"date":"2022-12-23","current":12.344611,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":962827235.26},{"date":"2022-12-30","current":11.726627,"twenty":-42.839081,"median":-18.773401,"eighty":-8.237263,"marketCap":920296470.02},{"date":"2023-01-06","current":12.133592,"twenty":-42.839081,"median":-18.624892,"eighty":-8.048443,"marketCap":945665552.96},{"date":"2023-01-13","current":12.811868,"twenty":-42.839081,"median":-18.428625,"eighty":-7.570472,"marketCap":1017866360.49},{"date":"2023-01-20","current":12.984453,"twenty":-42.839081,"median":-18.304887,"eighty":-7.32615,"marketCap":1033254554.62},{"date":"2023-01-27","current":12.125354,"twenty":-42.839081,"median":-18.158096,"eighty":-7.01265,"marketCap":966566528.44},{"date":"2023-02-03","current":12.340128,"twenty":-42.839081,"median":-18.049199,"eighty":-6.795134,"marketCap":983366945.2},{"date":"2023-02-10","current":11.450885,"twenty":-42.839081,"median":-18.018644,"eighty":-6.204351,"marketCap":897984697.78},{"date":"2023-02-17","current":10.893225,"twenty":-42.839081,"median":-17.910447,"eighty":-6.153481,"marketCap":852977359.78},{"date":"2023-02-24","current":10.226293,"twenty":-42.839081,"median":-17.842445,"eighty":-5.989651,"marketCap":792305699.51},{"date":"2023-03-03","current":10.557875,"twenty":-42.839081,"median":-17.756223,"eighty":-5.87938,"marketCap":821810905.24},{"date":"2023-03-10","current":10.015286,"twenty":-42.839081,"median":-17.564595,"eighty":-5.801877,"marketCap":784398977.18},{"date":"2023-03-17","current":9.495305,"twenty":-42.839081,"median":-17.481991,"eighty":-5.525382,"marketCap":743277601.54},{"date":"2023-03-24","current":-4.470623,"twenty":-42.839081,"median":-17.426261,"eighty":-5.333021,"marketCap":689056003.66},{"date":"2023-03-31","current":-4.664705,"twenty":-42.833778,"median":-17.266785,"eighty":-4.977808,"marketCap":726156238.59},{"date":"2023-04-06","current":-4.964999,"twenty":-42.833778,"median":-17.106519,"eighty":-4.790809,"marketCap":776870273.02},{"date":"2023-04-14","current":-5.003622,"twenty":-42.839081,"median":-16.971349,"eighty":-4.783664,"marketCap":792345256.41},{"date":"2023-04-21","current":-4.616426,"twenty":-42.844383,"median":-16.825814,"eighty":-4.712404,"marketCap":725498359.11},{"date":"2023-04-28","current":-4.242747,"twenty":-42.844383,"median":-16.736636,"eighty":-4.632477,"marketCap":670006146.81},{"date":"2023-05-05","current":-6.050412,"twenty":-42.844383,"median":-16.631541,"eighty":-4.572227,"marketCap":901203840.23},{"date":"2023-05-12","current":-5.733583,"twenty":-42.844383,"median":-16.313716,"eighty":-4.572227,"marketCap":847484701.9},{"date":"2023-05-19","current":-5.811257,"twenty":-42.844383,"median":-16.089624,"eighty":-4.572227,"marketCap":847034413.7},{"date":"2023-05-26","current":-5.582323,"twenty":-42.844383,"median":-15.932816,"eighty":-4.572227,"marketCap":810436657.01},{"date":"2023-06-02","current":-5.725407,"twenty":-42.844383,"median":-15.742193,"eighty":-4.572227,"marketCap":832101904.66},{"date":"2023-06-09","current":-6.179188,"twenty":-42.844383,"median":-15.55694,"eighty":-4.572227,"marketCap":901245305.46},{"date":"2023-06-16","current":-6.937533,"twenty":-42.844383,"median":-15.383101,"eighty":-4.572227,"marketCap":1025889466.9},{"date":"2023-06-23","current":-7.489429,"twenty":-42.849686,"median":-15.248121,"eighty":-4.561679,"marketCap":1111142679.75},{"date":"2023-06-30","current":-6.823066,"twenty":-42.849686,"median":-15.164817,"eighty":-4.561679,"marketCap":1005557275.99},{"date":"2023-07-07","current":-6.647209,"twenty":-42.849686,"median":-15.134116,"eighty":-4.561679,"marketCap":977405442.1},{"date":"2023-07-14","current":-7.104435,"twenty":-42.849686,"median":-15.093987,"eighty":-4.561679,"marketCap":1076440436.53},{"date":"2023-07-21","current":-6.993717,"twenty":-42.849686,"median":-15.020112,"eighty":-4.561679,"marketCap":1055176638.43},{"date":"2023-07-28","current":-6.938358,"twenty":-42.849686,"median":-14.963109,"eighty":-4.561679,"marketCap":1032213184.97},{"date":"2023-08-04","current":-6.825589,"twenty":-42.827429,"median":-14.906107,"eighty":-4.561679,"marketCap":1011656439.29},{"date":"2023-08-11","current":-6.883769,"twenty":-42.794213,"median":-14.742545,"eighty":-4.561679,"marketCap":1026461140.12},{"date":"2023-08-18","current":-6.106603,"twenty":-42.794213,"median":-14.649597,"eighty":-4.561679,"marketCap":899184439.25},{"date":"2023-08-25","current":-6.387531,"twenty":-42.684257,"median":-14.621095,"eighty":-4.561679,"marketCap":936475812.85},{"date":"2023-09-01","current":-6.60079,"twenty":-42.500908,"median":-14.580341,"eighty":-4.561679,"marketCap":969106274.4},{"date":"2023-09-08","current":-6.514666,"twenty":-42.500908,"median":-14.526273,"eighty":-4.561679,"marketCap":943668066.35},{"date":"2023-09-15","current":-6.45725,"twenty":-42.500908,"median":-14.485408,"eighty":-4.561679,"marketCap":932358069.33},{"date":"2023-09-22","current":-119.651677,"twenty":-42.618892,"median":-14.450088,"eighty":-4.561679,"marketCap":871678672.42},{"date":"2023-09-29","current":-112.501017,"twenty":-42.827429,"median":-14.450088,"eighty":-4.561679,"marketCap":812137517.96},{"date":"2023-10-06","current":-109.372603,"twenty":-42.827429,"median":-14.450088,"eighty":-4.561679,"marketCap":786727334.18},{"date":"2023-10-13","current":-108.519399,"twenty":-42.827429,"median":-14.450088,"eighty":-4.561679,"marketCap":782237322.22},{"date":"2023-10-20","current":-103.562691,"twenty":-42.827429,"median":-14.450088,"eighty":-4.561679,"marketCap":748323961.92},{"date":"2023-10-27","current":-105.675386,"twenty":-42.95965,"median":-14.435837,"eighty":-4.547895,"marketCap":760293006.53},{"date":"2023-11-03","current":-120.54551,"twenty":-43.150819,"median":-14.435837,"eighty":-4.547895,"marketCap":874274865.18},{"date":"2023-11-10","current":-7.776276,"twenty":-43.150819,"median":-14.38783,"eighty":-4.547895,"marketCap":945273657.2},{"date":"2023-11-17","current":-6.920128,"twenty":-42.880945,"median":-13.983711,"eighty":-4.547895,"marketCap":852988795.35},{"date":"2023-11-24","current":-6.3673,"twenty":-42.841815,"median":-13.822769,"eighty":-4.547895,"marketCap":787927360.96},{"date":"2023-12-01","current":-6.350177,"twenty":-42.592509,"median":-13.606329,"eighty":-4.547895,"marketCap":785894166.21},{"date":"2023-12-08","current":-6.276793,"twenty":-42.369364,"median":-13.399726,"eighty":-4.549512,"marketCap":768431429.5},{"date":"2023-12-15","current":-6.08844,"twenty":-42.238556,"median":-13.235496,"eighty":-4.549512,"marketCap":759632509.07},{"date":"2023-12-22","current":-5.567413,"twenty":-42.186086,"median":-13.158051,"eighty":-4.549512,"marketCap":694473074.64},{"date":"2023-12-29","current":-5.772888,"twenty":-42.199204,"median":-13.128089,"eighty":-4.547895,"marketCap":725607565.35},{"date":"2024-01-05","current":-5.946564,"twenty":-42.212321,"median":-13.037624,"eighty":-4.546277,"marketCap":739491923.29},{"date":"2024-01-12","current":-5.352152,"twenty":-41.976205,"median":-12.971666,"eighty":-4.546277,"marketCap":664917341.8},{"date":"2024-01-19","current":-4.903286,"twenty":-41.818504,"median":-12.852235,"eighty":-4.54466,"marketCap":604520176.01},{"date":"2024-01-26","current":-4.639103,"twenty":-41.556299,"median":-12.798495,"eighty":-4.546277,"marketCap":570523681.59},{"date":"2024-02-02","current":-4.334559,"twenty":-41.320183,"median":-12.751807,"eighty":-4.51195,"marketCap":533590837.49},{"date":"2024-02-09","current":-4.473988,"twenty":-41.031741,"median":-12.718828,"eighty":-4.471969,"marketCap":546486377.83},{"date":"2024-02-16","current":-4.487442,"twenty":-40.467685,"median":-12.630885,"eighty":-4.471969,"marketCap":547834869.28},{"date":"2024-02-23","current":-4.027568,"twenty":-40.179099,"median":-12.586913,"eighty":-4.386963,"marketCap":494351856.14},{"date":"2024-03-01","current":-3.858785,"twenty":-25.691288,"median":-12.448473,"eighty":-4.242747,"marketCap":473327826.18},{"date":"2024-03-08","current":-4.085052,"twenty":-25.195495,"median":-12.397276,"eighty":-4.161059,"marketCap":506613462.3},{"date":"2024-03-15","current":-4.233044,"twenty":-24.667694,"median":-12.334076,"eighty":-4.161059,"marketCap":523194254.44},{"date":"2024-03-22","current":-4.223259,"twenty":-24.488967,"median":-12.224146,"eighty":-4.118076,"marketCap":520397808.67},{"date":"2024-03-28","current":-4.976597,"twenty":-24.179168,"median":-12.152693,"eighty":-4.118076,"marketCap":545227155.97},{"date":"2024-04-05","current":-5.095642,"twenty":-23.715621,"median":-12.04039,"eighty":-4.114406,"marketCap":561422812.3},{"date":"2024-04-12","current":-5.495193,"twenty":-23.451754,"median":-11.982302,"eighty":-4.114406,"marketCap":596949646.57},{"date":"2024-04-19","current":-5.010806,"twenty":-23.196096,"median":-11.909228,"eighty":-4.114406,"marketCap":541950304.97},{"date":"2024-04-26","current":-4.712511,"twenty":-23.153903,"median":-11.795422,"eighty":-4.118076,"marketCap":512035620.78},{"date":"2024-05-03","current":-4.698827,"twenty":-22.883852,"median":-11.647018,"eighty":-4.118076,"marketCap":509893412.86},{"date":"2024-05-10","current":-19.140008,"twenty":-22.420022,"median":-11.608406,"eighty":-4.118076,"marketCap":503051638.83},{"date":"2024-05-17","current":-23.327597,"twenty":-22.244817,"median":-11.608406,"eighty":-4.118076,"marketCap":618510936.96},{"date":"2024-05-24","current":-22.133891,"twenty":-22.139768,"median":-11.608406,"eighty":-4.118076,"marketCap":584383597.79},{"date":"2024-05-31","current":-23.46877,"twenty":-22.139768,"median":-11.608406,"eighty":-4.118076,"marketCap":620769583.6},{"date":"2024-06-07","current":-22.065436,"twenty":-22.074563,"median":-11.608406,"eighty":-4.118076,"marketCap":585682453.75},{"date":"2024-06-14","current":-18.711124,"twenty":-21.834695,"median":-11.608406,"eighty":-4.118076,"marketCap":491302969.86},{"date":"2024-06-21","current":-17.707113,"twenty":-21.688129,"median":-11.607209,"eighty":-4.114406,"marketCap":462847840.76},{"date":"2024-06-28","current":-18.163482,"twenty":-21.57537,"median":-11.479685,"eighty":-4.098262,"marketCap":474319463.65},{"date":"2024-07-05","current":-18.266165,"twenty":-21.47676,"median":-11.479685,"eighty":-4.098262,"marketCap":481693575.14},{"date":"2024-07-12","current":-19.601044,"twenty":-21.005765,"median":-11.479685,"eighty":-4.098262,"marketCap":519761127.3},{"date":"2024-07-15","current":-19.156084,"twenty":-20.961672,"median":-11.479685,"eighty":-4.098262,"marketCap":510013490.5},{"date":"2024-08-02","current":-17.969525,"twenty":-20.284536,"median":-11.187293,"eighty":-4.065483,"marketCap":472746573.55},{"date":"2024-08-09","current":-17.764159,"twenty":-20.284536,"median":-11.457552,"eighty":-4.17226,"marketCap":472748342.79},{"date":"2024-08-16","current":-14.556338,"twenty":-20.284536,"median":-11.647018,"eighty":-4.223259,"marketCap":518153824.69},{"date":"2024-08-23","current":-14.82256,"twenty":-20.284536,"median":-11.795422,"eighty":-4.244086,"marketCap":533549596.8},{"date":"2024-08-30","current":-14.126947,"twenty":-20.284536,"median":-11.915612,"eighty":-4.334559,"marketCap":507102330.53},{"date":"2024-09-06","current":-13.225227,"twenty":-20.284536,"median":-11.976806,"eighty":-4.446484,"marketCap":475155147.45},{"date":"2024-09-13","current":-12.065873,"twenty":-20.284536,"median":-12.038828,"eighty":-4.527804,"marketCap":431492767.6},{"date":"2024-09-20","current":-12.679194,"twenty":-20.284536,"median":-12.098648,"eighty":-4.57428,"marketCap":457668339.27},{"date":"2024-09-27","current":-13.729956,"twenty":-20.284536,"median":-12.196663,"eighty":-4.615865,"marketCap":497313821.39},{"date":"2024-10-04","current":-13.079484,"twenty":-20.284536,"median":-12.317587,"eighty":-4.630909,"marketCap":466865118.41},{"date":"2024-10-11","current":-12.569114,"twenty":-20.284536,"median":-12.386766,"eighty":-4.657449,"marketCap":445020515.68},{"date":"2024-10-18","current":-13.309651,"twenty":-20.284536,"median":-12.417638,"eighty":-4.676934,"marketCap":467055614.51},{"date":"2024-10-25","current":-13.527884,"twenty":-20.284536,"median":-12.525184,"eighty":-4.712511,"marketCap":473534389.72},{"date":"2024-10-31","current":-12.936665,"twenty":-20.284536,"median":-12.597906,"eighty":-4.742614,"marketCap":455199257.33},{"date":"2024-11-08","current":-52.839095,"twenty":-20.409931,"median":-12.61915,"eighty":-4.870263,"marketCap":422781155.22},{"date":"2024-11-15","current":-47.717161,"twenty":-20.613798,"median":-12.714502,"eighty":-4.922401,"marketCap":374487837.49},{"date":"2024-11-22","current":-44.871643,"twenty":-21.000301,"median":-12.751807,"eighty":-4.964999,"marketCap":349163795.24},{"date":"2024-11-29","current":-40.384478,"twenty":-21.396609,"median":-12.759252,"eighty":-4.976597,"marketCap":316037621.06},{"date":"2024-12-06","current":-42.24501,"twenty":-21.57537,"median":-12.783899,"eighty":-5.00718,"marketCap":331226597.61},{"date":"2024-12-13","current":-40.078038,"twenty":-21.734568,"median":-12.842733,"eighty":-5.054971,"marketCap":311830170.97},{"date":"2024-12-20","current":-42.113678,"twenty":-21.858522,"median":-12.936665,"eighty":-5.094547,"marketCap":324334786.13},{"date":"2024-12-27","current":-46.929172,"twenty":-22.07,"median":-12.982659,"eighty":-5.198446,"marketCap":362550089.56},{"date":"2025-01-03","current":-49.205587,"twenty":-22.154919,"median":-13.032666,"eighty":-5.320372,"marketCap":374327804.33},{"date":"2025-01-10","current":-48.505151,"twenty":-22.420022,"median":-13.084488,"eighty":-5.385854,"marketCap":370404789.99},{"date":"2025-01-17","current":-45.353192,"twenty":-22.669011,"median":-13.158051,"eighty":-5.469687,"marketCap":346335164.71},{"date":"2025-01-24","current":-49.730913,"twenty":-22.889342,"median":-13.183446,"eighty":-5.525382,"marketCap":384074872.46},{"date":"2025-01-31","current":-59.712118,"twenty":-23.072569,"median":-13.224865,"eighty":-5.576219,"marketCap":461737192.74},{"date":"2025-02-07","current":-68.423783,"twenty":-23.164066,"median":-13.263244,"eighty":-5.67316,"marketCap":526631689.15},{"date":"2025-02-14","current":-73.326831,"twenty":-23.250681,"median":-13.328938,"eighty":-5.732413,"marketCap":568081912.27},{"date":"2025-02-21","current":-81.162952,"twenty":-23.44002,"median":-13.378629,"eighty":-5.794653,"marketCap":630040578.69},{"date":"2025-02-28","current":-72.276178,"twenty":-23.596448,"median":-13.439834,"eighty":-5.807815,"marketCap":557902899.06},{"date":"2025-03-07","current":-73.107945,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":587302072.77},{"date":"2025-03-14","current":-68.94911,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":555637691.47},{"date":"2025-03-21","current":-44.898908,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":596654649.52},{"date":"2025-03-28","current":-43.44029,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":574280260.15},{"date":"2025-04-04","current":-34.662063,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":469898479.08},{"date":"2025-04-11","current":-36.783689,"twenty":-23.596448,"median":-13.439834,"eighty":-5.807815,"marketCap":503847263.17},{"date":"2025-04-17","current":-40.257851,"twenty":-23.596448,"median":-13.439834,"eighty":-5.807815,"marketCap":560652609.73},{"date":"2025-04-25","current":-43.04583,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":598594612.24},{"date":"2025-04-30","current":-39.442754,"twenty":-23.549255,"median":-13.439745,"eighty":-5.807116,"marketCap":548054700.48}],"updateTime":1746127091606}}}